These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 33673480)

  • 1. Multiple Myeloma Bone Disease: Implication of MicroRNAs in Its Molecular Background.
    Papanota AM; Karousi P; Kontos CK; Ntanasis-Stathopoulos I; Scorilas A; Terpos E
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33673480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Cancer-Related microRNA Signature Shows Biomarker Utility in Multiple Myeloma.
    Papanota AM; Karousi P; Kontos CK; Artemaki PI; Liacos CI; Papadimitriou MA; Bagratuni T; Eleutherakis-Papaiakovou E; Malandrakis P; Ntanasis-Stathopoulos I; Gavriatopoulou M; Kastritis E; Avgeris M; Dimopoulos MA; Scorilas A; Terpos E
    Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Molecular Signature of Circulating MicroRNA Can Predict Osteolytic Bone Disease in Multiple Myeloma.
    Papanota AM; Tsiakanikas P; Kontos CK; Malandrakis P; Liacos CI; Ntanasis-Stathopoulos I; Kanellias N; Gavriatopoulou M; Kastritis E; Avgeris M; Dimopoulos MA; Scorilas A; Terpos E
    Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-Coding RNAs in Multiple Myeloma Bone Disease Pathophysiology.
    Raimondi L; De Luca A; Giavaresi G; Raimondo S; Gallo A; Taiana E; Alessandro R; Rossi M; Neri A; Viglietto G; Amodio N
    Noncoding RNA; 2020 Sep; 6(3):. PubMed ID: 32916806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of multiple myeloma bone disease.
    Galson DL; Silbermann R; Roodman GD
    Bonekey Rep; 2012; 1():135. PubMed ID: 23951515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myeloma bone disease: Pathophysiology and management.
    Silbermann R; Roodman GD
    J Bone Oncol; 2013 Jun; 2(2):59-69. PubMed ID: 26909272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs-containing extracellular vesicles in bone remodeling: An emerging frontier.
    Huang X; Xiong X; Liu J; Zhao Z; Cen X
    Life Sci; 2020 Aug; 254():117809. PubMed ID: 32428598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-talk of MicroRNA and hydrogen sulfide: A novel therapeutic approach for bone diseases.
    Zhai Y; Tyagi SC; Tyagi N
    Biomed Pharmacother; 2017 Aug; 92():1073-1084. PubMed ID: 28618652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The emerging role of exosomes in multiple myeloma.
    Moloudizargari M; Abdollahi M; Asghari MH; Zimta AA; Neagoe IB; Nabavi SM
    Blood Rev; 2019 Nov; 38():100595. PubMed ID: 31445775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miRNA and cancer; computational and experimental approaches.
    Tutar Y
    Curr Pharm Biotechnol; 2014; 15(5):429. PubMed ID: 25189575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs in the pathobiology of multiple myeloma.
    Lionetti M; Agnelli L; Lombardi L; Tassone P; Neri A
    Curr Cancer Drug Targets; 2012 Sep; 12(7):823-37. PubMed ID: 22671930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential role of miRNAs in multiple myeloma therapy.
    Caracciolo D; Montesano M; Altomare E; Scionti F; Di Martino MT; Tagliaferri P; Tassone P
    Expert Rev Hematol; 2018 Oct; 11(10):793-803. PubMed ID: 30148649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs and exosomes: Small molecules with big actions in multiple myeloma pathogenesis.
    Pourhanifeh MH; Mahjoubin-Tehran M; Shafiee A; Hajighadimi S; Moradizarmehri S; Mirzaei H; Asemi Z
    IUBMB Life; 2020 Mar; 72(3):314-333. PubMed ID: 31828868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of microRNAs in Diagnosis, Prognosis and Management of Multiple Myeloma.
    Soliman AM; Lin TS; Mahakkanukrauh P; Das S
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33066062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Evidence-Based Approach to Myeloma Bone Disease.
    Bingham N; Reale A; Spencer A
    Curr Hematol Malig Rep; 2017 Apr; 12(2):109-118. PubMed ID: 28243849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant microRNA expression in multiple myeloma.
    Dimopoulos K; Gimsing P; Grønbæk K
    Eur J Haematol; 2013 Aug; 91(2):95-105. PubMed ID: 23586898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered microRNA expression profile in the peripheral lymphoid compartment of multiple myeloma patients with bisphosphonate-induced osteonecrosis of the jaw.
    Musolino C; Oteri G; Allegra A; Mania M; D'Ascola A; Avenoso A; Innao V; Allegra AG; Campo S
    Ann Hematol; 2018 Jul; 97(7):1259-1269. PubMed ID: 29546453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiRNome expression is deregulated in the peripheral lymphoid compartment of multiple myeloma.
    Campo S; Allegra A; D'Ascola A; Alonci A; Scuruchi M; Russo S; Avenoso A; Gerace D; Campo GM; Musolino C
    Br J Haematol; 2014 Jun; 165(6):801-13. PubMed ID: 24620752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA and multiple myeloma: from laboratory findings to translational therapeutic approaches.
    Rossi M; Amodio N; Di Martino MT; Tagliaferri P; Tassone P; Cho WC
    Curr Pharm Biotechnol; 2014; 15(5):459-67. PubMed ID: 24846067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNAs: Novel Crossroads between Myeloma Cells and the Bone Marrow Microenvironment.
    Raimondi L; De Luca A; Morelli E; Giavaresi G; Tagliaferri P; Tassone P; Amodio N
    Biomed Res Int; 2016; 2016():6504593. PubMed ID: 26881223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.